GLP-R

Product Overview

GLP-R (Research Grade Retatrutide) is a synthetic research peptide engineered as a triple receptor agonist targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors. It is a 39-amino acid peptide developed with structural modifications to enhance its metabolic stability, receptor selectivity, and prolonged activity in vivo. This compound is intended strictly for laboratory research use.

Key Features

• Peptide Sequence: Modified hybrid peptide structure derived from native GIP with amino acid substitutions and a C20 diacid side chain conjugated to improve half-life and receptor activity across GLP-1, GIP, and GCGR pathways.

• Molecular Formula: C250H375N61O76

• Molecular Weight: 5192.66 Da

• CAS Number: 3030305-78-4

Intended Research Applications

• Investigation of triple hormone receptor signaling (GLP-1R, GIPR, GCGR)

• Research on metabolic regulation, including energy expenditure and glucose control

• Preclinical studies in obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD)

• Evaluation of pharmacokinetics and receptor synergy across metabolic pathways

Product Attributes

Compliance Disclaimer

For Research Use Only: This product is not intended for human or veterinary use. Supply is limited strictly to laboratory research, analytical assay development, or investigative procedures only.

Not for Human Consumption: Any clinical or diagnostic use, or use as a drug, food, or cosmetic is strictly prohibited.

Handling Precautions: Employ appropriate personal protective equipment and follow institutional safety protocols for peptide handling and disposal.

Additional Information

GLP-R (Research Grade Retatrutide) should be reconstituted with 0.9% benzyl alcohol solution (Bacteriostatic Water) in accordance with your laboratory’s protocols.

No therapeutic or diagnostic claims are made for this compound. All statements relate exclusively to laboratory research findings.